BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V, Colaci M, Giuggioli D, Ferri C, Antonelli A. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? J Immunol Res 2019;2019:5878960. [PMID: 31485460 DOI: 10.1155/2019/5878960] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferreira H, Mendes MA, de Mattos Barbosa MG, de Oliveira EB, Sales AM, Moraes MO, Sarno EN, Pinheiro RO. Potential Role of CXCL10 in Monitoring Response to Treatment in Leprosy Patients. Front Immunol 2021;12:662307. [PMID: 34354699 DOI: 10.3389/fimmu.2021.662307] [Reference Citation Analysis]
2 Chan PC, Hsieh PS. The Chemokine Systems at the Crossroads of Inflammation and Energy Metabolism in the Development of Obesity. Int J Mol Sci 2021;22:13528. [PMID: 34948325 DOI: 10.3390/ijms222413528] [Reference Citation Analysis]
3 Chang S, Wang LH, Chen BS. Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method. Biomedicines. 2020;8. [PMID: 32878239 DOI: 10.3390/biomedicines8090320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Liu M, Chen HY, Luo L, Wang Y, Zhang D, Song N, Wang FB, Li Q, Zhang XL, Pan Q. Neutralization of IL-10 produced by B cells promotes protective immunity during persistent HCV infection in humanized mice. Eur J Immunol 2020;50:1350-61. [PMID: 32339264 DOI: 10.1002/eji.201948488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bolina-Santos E, Chaves DG, da Silva-Malta MCF, Carmo RA, Barbosa-Stancioli EF, Lobato Martins M. HCV infection in hemophilia A patients is associated with altered cytokines and chemokines profile and might modulate the levels of FVIII inhibitor. J Med Virol 2022;94:683-91. [PMID: 34738645 DOI: 10.1002/jmv.27432] [Reference Citation Analysis]
6 Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, Patrizio A, Giusti C, Gonnella D, Cristaudo A, Foddis R, Shoenfeld Y, Fallahi P. Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab 2020;34:101387. [PMID: 32107168 DOI: 10.1016/j.beem.2020.101387] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
7 Spencer Clinton JL, Tran LL, Vogt MB, Rowley DR, Kimata JT, Rico-Hesse R. IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells. PLoS One 2020;15:e0244587. [PMID: 33378361 DOI: 10.1371/journal.pone.0244587] [Reference Citation Analysis]
8 Azhar A, Tsujita M, Talwar M, Balaraman V, Bhalla A, Eason JD, Nouer SS, Sumida K, Remport A, Hall IE, Griffin R, Rofaiel G, Molnar MZ. CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors. Ren Fail 2022;44:831-41. [PMID: 35546431 DOI: 10.1080/0886022X.2022.2072744] [Reference Citation Analysis]
9 Magri MC, Alvarez MSM, Iogi AA, Alves GM, Manchiero C, Dantas BP, Prata TVG, Nunes AKDS, Tengan FM. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C. Pathog Dis 2021;79:ftab007. [PMID: 33476381 DOI: 10.1093/femspd/ftab007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Salgüero S, Medrano LM, González-García J, Berenguer J, Montes ML, Diéz C, Garcia-Broncano P, Llop-Herrera E, Pérez-Latorre L, Bellóno JM, Jiménez-Sousa MÁ, Resino S. Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study. Sci Rep 2020;10:10384. [PMID: 32587340 DOI: 10.1038/s41598-020-67159-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Colucci G, Invernizzi F, Uceda Renteria S, Perbellini R, Degasperi E, D'Ambrosio R, Galmozzi E, Lunghi G, Sguazzini E, Lampertico P, Donato MF. The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics Profiles. Viral Immunol 2021. [PMID: 34252334 DOI: 10.1089/vim.2021.0035] [Reference Citation Analysis]